可调穿刺装置用于胸主动脉腔内修复术中原位开窗的中期结果
本研究评估可调穿刺装置在胸主动脉腔内修复术(TEVAR)中行原位开窗(ISF)保留主动脉弓分支的中期结局。2016年10月至2019年4月纳入需近端锚定区超过3区的复杂型B型主动脉夹层、直径>5.5 cm的胸主动脉瘤或基底>20 mm或深度>15 mm的主动脉穿透性溃疡患者,51例中50例(98%)ISF成功。中位随访31个月,中期结果示该装置辅助保留主动脉弓分支有效且安全。
要点
- 51例中50例(98%)成功完成可调穿刺装置辅助的原位开窗。
- 44例、6例、1例分别保留1、2、3支主动脉弓分支。
- 中位随访31个月,所有再血管化动脉末次随访均通畅。
核心结论
- 在这项迄今最大的机械性原位开窗研究中,可调穿刺装置有助于在累及主动脉弓的主动脉疾病腔内修复中实施原位开窗,成功率高。
- 中期结果证明该装置在辅助保留主动脉弓分支方面有效且安全。
研究设计与样本
- 研究纳入2016年10月至2019年4月期间因复杂型B型主动脉夹层、直径>5.5 cm的胸主动脉瘤或基底>20 mm或深度>15 mm的主动脉穿透性溃疡接受TEVAR、需近端锚定区超过3区并使用可调穿刺装置行原位开窗的患者。
- 术后1、3、6、12个月及此后每年随访,收集并分析围手术期和随访数据。
主要发现
- 51例患者中50例(98%)成功完成原位开窗。
- 44例、6例、1例患者分别保留1、2、3支主动脉弓分支。
- 术中造影发现8例Ia型内漏和1例II型内漏。
- 1例患者术后3天因严重卒中死于脑疝;1例出现暂时性截瘫但两周内恢复;1例发生非致残性卒中。
- 中位随访31个月(22.5-36.5个月);6个月随访时9例未处理的内漏均消失;1例患者1个月随访时发现新发Ia型内漏,一年后自行消退;末次随访所有再血管化动脉均通畅;未发现支架骨折、移位或桥接支架扭结。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the midterm outcomes of in situ fenestration (ISF) with an adjustable puncture device for aortic arch branch preservation during thoracic endovascular aortic repair (TEVAR). METHODS: From October 2016 to April 2019, patients with complicated type B aortic dissection, thoracic aortic aneurysm > 5.5 cm in diameter, or aortic penetrating ulcer with a base > 20 mm or depth > 15 mm, who received TEVAR requiring a proximal sealing beyond zone 3 and underwent ISF using an adjustable puncture device, were included. After the procedure, patients were monitored at one, three, six, and 12 months, and annually thereafter. Peri-operative and follow up data were collected and analysed. RESULTS: Fifty of 51 patients (98%) received successful ISFs. One, two, or three aortic arch branches were preserved in 44, six, and one patient, respectively. Intra-operatively, eight type Ia endoleaks and one type II endoleak were found on angiography. One patient died of cerebral hernia three days post-procedure from a severe stroke; one patient suffered from transient paraplegia but recovered in two weeks; one patient had a non-disabling stroke. The median follow up was 31 months (22.5 - 36.5 months). At six month follow up, all nine unmanaged endoleaks had disappeared. One new type Ia endoleak was identified in a patient at the one month follow up which resolved spontaneously one year later. All revascularised arteries were patent at the last follow up. No fractures, migrations, or bridging stent kinks were found. CONCLUSION: In this largest mechanical based ISF study to date, an adjustable puncture device was shown to facilitate the procedure of ISF during endovascular repair of aortic diseases involving the aortic arch, with high success. The midterm outcome demonstrates the efficacy and safety of the device in assisting with preservation of aortic arch branches.
引用
- Shu X, Xu H, Wang E, et al. Midterm Outcomes of an Adjustable Puncture Device for In Situ Fenestration During Thoracic Endovascular Aortic Repair. Eur J Vasc Endovasc Surg. 2021. PMID: 34750032. doi:10.1016/j.ejvs.2021.09.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。